Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS (London) 2004-11, Vol.18 (16), p.2213-2215
Hauptverfasser:	OPRAVIL, Milos, BAUMANN, Doris, CHAVE, Jean-Philippe, FURRER, Hansjakob, CALMY, Alexandra, BERNASCONI, Enos, BLASKO, Monika, VERNAZZA, Pietro, LEDERGERBER, Bruno, PERRIN, Luc
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult AIDS/HIV Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral Therapy, Highly Active Antiviral agents Biological and medical sciences Dideoxynucleosides - administration & dosage Female Follow-Up Studies HIV Infections - drug therapy HIV Protease Inhibitors - therapeutic use Human viral diseases Humans Infectious diseases Lamivudine - administration & dosage Male Medical sciences Middle Aged Pharmacology. Drug treatments Prospective Studies Reverse Transcriptase Inhibitors - therapeutic use Time Factors Treatment Failure Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Zidovudine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!